
Biodesix named Company of the Year by CBSA
BOULDER -- Biodesix, Inc. has been named Company of the Year by the Colorado BioScience Association ( CBSA). The company received the honor at the 16 th Annual CBSA Awards Dinner on Nov. 7. ... Read More
Monday November 11, 2019 0 comments

Biodesix names James Jett new chief medical officer
BOULDER -- Biodesix, Inc . announced the appointment of internationally recognized lung cancer expert James Jett , M.D., as chief medical officer. Dr. Jett joins Steven Springmeyer , M.D.... Read More
Wednesday October 16, 2019 0 comments

Biodesix issued new patent for improved blood specimen collection device
BOULDER -- Biodesix, Inc . announced it has been issued U.S. Patent Number 10,422,729, which covers the Biodesix Collection Device (BCD). The new device offers improved ease-of-use in blood... Read More
Friday October 4, 2019 0 comments

Biodesix appoints Robert Georgantas senior VP
BOULDER -- Biodesix, Inc . announced the appointment of Robert W. Georgantas III, Ph.D., as the companys senior vice president of research and translational science. Georgantas research... Read More
Wednesday August 14, 2019 0 comments

Biodesix and MRM Proteomics partner to develop precision lung cancer diagnostics
BOULDER-- Biodesix and Canada-based MRM Proteomics Inc. announced they will partner to create novel assays to answer critical clinical questions within the lung cancer continuum of care. ... Read More
Tuesday January 29, 2019 0 comments